My health system is looking for ideas to optimize our risk reduction strategies for EPINEPHrine administration errors for anaphylaxis in the acute and ambulatory settings.
1. Are you using autoinjectors?
2. Are you using "kits" with ampules or vials?
Please provide details on how you've managed either strategy.
Thanks in advance,